ViennaLab Diagnostics
FCGR StripAssay®
Fc Gamma Receptor Polymorphism Identification
The FCGR StripAssay® identifies germline polymorphisms in the Fc gamma receptor, aiding determination of optimal cancer treatment strategies based on individual FCGR genotype.
Key Features
01
Germline Polymorphism Detection
Identifies germline polymorphisms in Fc gamma receptor genes relevant to cancer therapy response.
02
Cancer Therapy Optimization
Aids determination of the most effective cancer treatment by linking FCGR genotype to therapy outcomes.
03
Reverse Hybridization Technology
Based on reverse hybridization of biotinylated PCR products for clear, parallel mutation detection.
04
Minimal Equipment Required
Requires only a thermal cycler and shaking water bath for routine laboratory use.
For Research Use Only (RUO)
FCGR StripAssay® is intended for research use only in the United States and is not FDA-cleared for diagnostic use.